Stockreport

XOMA GAAP EPS of $0.70 beats by $0.74, revenue of $9.35M misses by $2.12M [Seeking Alpha]

LAVA Therapeutics N.V. - Ordinary Shares  (LVTX) 
PDF XOMA Royalty PFD Update: Going Back To My Original Sell Ratings XOMA extends tender offer for LAVA Therapeutics to Oct 17 Mural Oncology to be acquired by XOMA unit [Read more]